trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Dopamine deficiency is more frequent in addiction-prone individuals

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Multiple studies and reviews support the reward deficiency syndrome model, indicating that individuals prone to addiction frequently exhibit reduced dopamine signaling and lower baseline dopaminergic function in the brain's reward pathways.

The analysis

The retrieved literature consistently links addiction, substance use disorders, and reward-seeking behaviors to hypodopaminergia or reduced dopamine signaling (Reward Deficiency Syndrome). Papers [0], [1], and [3] explicitly support the claim that addiction-prone individuals exhibit dopamine deficiency. No retrieved papers refute the claim.

Evidence for · 3
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
Recorded source metadata

Blum K, Bowirrat A, Braverman ER, Baron D, Cadet JL, Kazmi S, Elman I, Thanos PK, Badgaiyan RD, Downs WB, Bagchi D, Llanos-Gomez L, Gold MS. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.. 2021. https://doi.org/10.3390/ijerph182111529

States that substance use disorders and reward deficiency syndrome are characterized by a reduction in dopamine signaling within the reward pathway.

See more details
More for · 2
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.
Recorded source metadata

Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B, Martinez KC, Nami M, Manavi N, Sunder K, Rabin DM, Bagchi D, Khalsa J, Gold MS, Sipple D, Barzegar M, Bodhanapati J, Khader W, Carney P, Dennen CA, Gupta A, Elman I, Badgaiyan RD, Modestino EJ, Thanos PK, Hanna C, McLaughlin T, Cadet JL, Soni D, Braverman ER, Barh D, Giordano J, Edwards D, Ashford JW, Gondre-Lewis MC, Gilley E, Murphy KT, Lewandrowski KU, Sharafshah A, Makale M, Fuehrlein B, Blum K. Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.. 2024. https://doi.org/10.17756/jap.2024-045

Emphasizes the need to assess pre-addiction vulnerability via genetic risk scoring to address dopamine deficiencies linked to addiction.

Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis.
Recorded source metadata

Lewandrowski KU, Alvim Fiorelli RK, Schmidt S, Sharafshah A, Baron D, Gold MS, Thanos PK, Elman I, Bagchi D, Bowirrat A, Pinhasov A, Lorio MP, Blum K. Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis.. 2025. https://doi.org/10.14444/8756

Notes that patients with inherently low dopaminergic function (hypodopaminergia) are particularly predisposed to reward deficiency behaviors and hyperalgesia.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8301 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt